COTA’s Vantage Products Give Access to Targeted Oncology Data Sets with Miruna Sasu
Summary The healthcare ecosystem generates approximately a third of all the new data in the world. And it holds untapped potential for developing new therapies and giving people the opportunity to live longer and healthier. But these data sets are raw and need to be meticulously tabulated into meaningful, targeted information. In this episode of […]
Using Real-World Data in Blood Cancer Research with Paul Barr, MD
Summary Blood cancers make up more than 100 different diagnoses in the current classification system. And there are three main groups of blood cancer: leukemia, lymphoma, and myeloma. One of the most common leukemias in adults is chronic lymphocytic leukemia (CLL). In this episode of Real World Talk, our host Ming He welcomes Paul Barr, […]
The Past, Present, and Future of Real World Data in the Pharma Industry With Karla Feghali of Deloitte
Summary Real world data is changing the pharma industry and allowing companies to maximize value while minimizing the time and money spent. In addition, technology is evolving, and new methodologies are being developed, all of which contribute to the change. However, we still need to work on things such as diversity and inclusion. In this […]
Learning How Combining RCTs and RWD Helps With Patient Outcomes Featuring Seshamalini Srinivasan, Laura Fernandes, and Karla Feghali
Summary Real world data (RWD) is data that’s collected outside of clinical trials, whereas randomized controlled trials (RCTs) are conducted to measure the effectiveness of a specific medication or treatment. But how can these two work together to improve patient outcomes? In this episode of the Real World Talk podcast, our host Mandy Kelly welcomes […]
How to Handle Potential Biases When Dealing With Real-World Data Featuring Laura Fernandes
Summary Real-world data holds great potential for clinical trials, and it can support clinical development and regulatory decision-making. But when working with data, we need to be conscious of potential biases. In this episode of the Real World Talk podcast, our host Christie Zettler welcomes Laura Fernandes, Senior Statistical Director at COTA. They talk about […]
Using Fit-for-Purpose Data to Improve Patient Outcomes With Seshamalini Srinivasan, Karla Feghali, Mandy Kelly, Laura Fernandes
Summary In the world of clinical trials, having a well-defined research question is key. And that’s where fit-for-purpose data sets come in. But what are the factors for defining research questions? In this episode of the Real World Talk podcast, we get to hear from Seshamalini Srinivasan, Karla Feghali, Mandy Kelly, and Laura Fernandes. They […]
Using Centralized Real-World Data to Improve Patient Outcomes With Marisa Co and David Anstatt
Summary Real-world data plays a vital role in the pharmaceutical industry, and it can immensely support clinical research and drug development. However, a centralized and coordinated data strategy could make a more significant impact. In this episode of the Real World Talk podcast, our host Miruna Sasu welcomes Marisa Co, Head of R&D Business Insights […]
Laura Fernandes and Sesh Srinivasan on Constructing Effective ECAs
Summary In this episode of Real World Talk, Sandy Leonard from COTA hosts a thought-provoking discussion with Laura Fernandes, Senior Statistical Director at COTA, and Sesh Srinivasan, Product Management Lead at Deloitte. The conversation revolves around the future of real world data and the exploration of external control arms (ECAs) in drug development. The guests […]
COTA Joins Aetion CARE Initiative
Summary In this episode of Real World Talk, host Sandy Leonard sits down with Ulka Campbell, Head of Scientific Strategy at Aetion, and CK Wang, Chief Medical Officer at COTA. They dive into the Aetion CARE program, a cross-industry initiative aimed at understanding real-world data’s role in evaluating oncology therapeutics. Campbell explains the importance of […]
COTA / Deloitte – data biases
Summary In the latest episode of Real World Talk, host Sandy Leonard sits down with experts Laura Fernandes and Sesh Srinivasan to dive into the pressing issue of bias in clinical research. Sandy sets the stage by highlighting recent regulatory responses and the growing attention on the topic, emphasizing its significance in the realm of […]
